Chordia Therapeutics Inc. (JP:190A) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chordia Therapeutics Inc., a Japanese biotech firm, was honored with the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024 for its innovative work in cancer therapy commercialization. The company, a university spin-out, has developed new anti-cancer drugs with significant financial milestones and royalties linked to future sales. Chordia’s efforts contribute to the drug discovery ecosystem and provide new treatment options for cancer patients.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.